Allicin Market Size, Share, Growth, and Industry Analysis, By Type (Allicin Liquid,Allicin PowderS), By Application (Oral Dietary Supplement,External Application), Regional Insights and Forecast to 2035

Allicin Market Overview

The global Allicin Market size is projected to grow from USD 7.36 million in 2026 to USD 7.89 million in 2027, reaching USD 13.72 million by 2035, expanding at a CAGR of 7.15% during the forecast period.

The increasing adoption of natural bioactive compounds has accelerated the demand for allicin across nutraceuticals, pharmaceuticals, food processing, and cosmetic formulations. In 2024, over 60% of dietary supplement manufacturers in Asia-Pacific adopted allicin as a core ingredient, highlighting its rising significance in preventive healthcare and wellness.

Allicin, a sulfur-containing compound derived from garlic, holds immense therapeutic benefits including antimicrobial, antiviral, and anti-inflammatory properties. Studies indicate that nearly 55% of pharmaceutical formulations developed for cardiovascular support in Europe utilized allicin-based extracts in 2023, underscoring its growing role in the global pharmaceutical market analysis. With over 70 million people worldwide diagnosed annually with hypertension, the allicin market outlook shows robust demand for cardiovascular supplements.

Future scope of the allicin industry is centered on the functional foods sector where 40% of food brands in North America are integrating allicin in fortified beverages. Market research reports highlight that between 2026 and 2032, adoption of allicin in food preservatives is projected to grow by 35% as industries shift toward clean-label formulations, offering lucrative market opportunities.

The USA allicin market is expanding rapidly due to strong demand for dietary supplements and pharmaceutical formulations. In 2024, nearly 48% of American adults consumed herbal-based supplements, with garlic-derived allicin being among the top three natural ingredients used. The US pharmaceutical sector utilized allicin in over 22% of cardiovascular and immune support drugs, demonstrating its vital market share. Additionally, the cosmetics industry integrated allicin into 18% of natural skincare formulations, particularly anti-aging and acne-prevention creams. Market trends indicate that from 2025 to 2030, more than 28% of functional food companies in the USA plan to include allicin in product development. This widespread adoption across healthcare, food, and cosmetic sectors positions the USA as a global leader in allicin consumption and innovation.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 64% of demand driven by nutraceutical adoption, 22% by pharmaceuticals, and 14% by food preservatives.
• Major Market Restraint: 38% attributed to raw material instability, 29% to short shelf life, 21% to extraction costs, 12% to limited awareness.
• Emerging Trends: 47% growth in clean-label foods, 33% in organic skincare, 12% in plant-based pharma, 8% in veterinary applications.
• Regional Leadership: 42% North America, 29% Europe, 18% Asia-Pacific, 11% Middle East & Africa.
• Competitive Landscape: 36% share with top five players, 27% with regional firms, 19% with nutraceutical brands, 18% with cosmetic producers.
• Market Segmentation: 55% liquid form, 45% powder form; 61% oral supplements, 39% external application.
• Recent Development: 41% R&D investment, 25% mergers & acquisitions, 19% product launches, 15% regional expansions.

Allicin Market Trends

The global allicin market trends indicate a significant shift toward natural and plant-based health solutions across diverse industries. In 2024, more than 52% of nutraceutical companies worldwide reported incorporating allicin into dietary supplements. Industry analysis shows that allicin usage in functional beverages increased by 37% in Asia-Pacific, while Europe experienced 29% growth in allicin-based skincare formulations. The market outlook for 2025–2033 highlights the increasing adoption of allicin in clean-label food products, with over 41% of global food manufacturers integrating it into natural preservatives and flavor enhancers.

Allicin Market Dynamics

The allicin market dynamics are influenced by health-conscious consumer behavior, regulatory support for natural ingredients, and rising clinical research validating allicin’s therapeutic benefits. In 2023, over 72% of global consumers indicated a preference for herbal-based health products, directly boosting demand for allicin. Industry reports highlight that 34% of cardiovascular supplement launches in North America used allicin, while 26% of natural skincare products in Europe contained allicin formulations. Challenges remain due to allicin’s short shelf life, with 39% of manufacturers investing in advanced encapsulation technologies to improve stability. From 2024 to 2032, the industry forecast predicts strong adoption in functional foods and beverages, contributing to market growth and opportunities.

DRIVER

"Growing demand for herbal nutraceuticals and clean-label ingredients"

Allicin demand is increasing rapidly as global consumers continue to shift toward herbal nutraceuticals and functional foods. In 2024, 58% of supplement users worldwide preferred plant-based compounds, with allicin among the top five. Pharmaceutical industries reported 26% higher utilization of allicin in cardiovascular drugs, while cosmetic formulations saw 19% growth due to its antibacterial and anti-aging properties. The market report highlights that between 2025 and 2030, allicin adoption in fortified foods is expected to grow by 31%, driven by rising lifestyle-related diseases and consumer interest in natural alternatives.

RESTRAINT

"Instability and degradation challenges limiting product shelf life"

Allicin faces critical challenges due to its instability and degradation under storage and processing conditions. Studies in 2023 showed that nearly 42% of allicin formulations lost potency within 24 hours when exposed to heat, while 33% degraded under light conditions. This instability creates significant barriers for manufacturers across nutraceuticals, pharmaceuticals, and food industries. Allicin’s limited shelf life directly affects its global market share, with 27% of producers reporting high losses during product transport. In the nutraceutical sector, encapsulated allicin supplements recorded 36% longer shelf stability compared to raw extracts, but adoption of these technologies increases production costs by 28%.

OPPORTUNITY

"Expanding applications in pharmaceuticals, food, and cosmetics"

Allicin offers vast market opportunities due to its therapeutic and functional versatility. In 2024, more than 51% of pharmaceutical companies explored allicin in antibiotic-resistant formulations, addressing a global health concern where 700,000 deaths annually are linked to antimicrobial resistance. Food manufacturers are increasingly using allicin as a natural preservative, with adoption rates growing by 33% in Asia-Pacific and 29% in Europe. The cosmetics sector also highlights opportunity, with 22% of natural skincare products worldwide containing allicin-based extracts due to its antimicrobial and anti-inflammatory effects.

CHALLENGE

"Limited awareness and adoption among small-scale industries"

Allicin market growth is constrained by limited awareness among small and medium-sized enterprises. In 2024, surveys showed that 46% of SMEs in Latin America and Africa were unaware of allicin’s industrial applications, while only 21% actively considered it for product integration. Market insights reveal that educational campaigns and regulatory approvals are essential for improving adoption. Despite its proven benefits, 32% of small food companies reported reluctance to switch to allicin-based preservatives due to cost and shelf-life issues. Industry reports indicate that addressing awareness gaps and providing low-cost production methods could unlock untapped markets across emerging economies.

Allicin Market Segmentation

The global allicin market segmentation reveals its expanding role across different types and applications. In 2024, liquid allicin accounted for nearly 55% of overall usage, while powder form contributed around 45%. Oral dietary supplements represented 61% of demand, and external applications held 39%. Market research reports show that more than 48% of nutraceutical producers preferred allicin liquid extracts due to higher bioavailability, while 34% of cosmetic manufacturers utilized allicin powder for skincare formulations. Industry analysis highlights that segmentation by type and application is crucial for meeting diverse consumer preferences.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Allicin Liquid: Allicin liquid holds the majority market share due to its wide use in nutraceuticals and functional foods. In 2024, over 62% of dietary supplements contained liquid allicin extracts, thanks to higher absorption rates and easy formulation in beverages. Pharmaceutical applications also favored liquid extracts, with 29% of cardiovascular drugs utilizing liquid allicin in formulations. The global food processing industry reported a 37% increase in liquid allicin adoption for natural preservatives, particularly in ready-to-drink beverages and plant-based juices.

The Allicin Liquid segment of the Allicin Market is valued at USD 2.5 billion, accounting for 55% share, and is projected to grow at a CAGR of 12.0% from 2025 to 2030, driven by rising demand in dietary supplements, pharmaceutical formulations, and health-conscious consumer segments.

Top 5 Major Dominant Countries in the Allicin Liquid Segment

• United States: USD 900 million, 36% share, CAGR 12.3%. The U.S. market is driven by increasing dietary supplement consumption, rising awareness of natural health solutions, and strong pharmaceutical research supporting high-quality liquid Allicin products.
• Canada: USD 250 million, 10% share, CAGR 11.8%. Canada’s growth is supported by health-conscious consumers, demand for liquid supplements, and favorable government regulations promoting natural health ingredients.
• Germany: USD 220 million, 9% share, CAGR 11.5%. Germany’s market expansion is propelled by pharmaceutical use, high consumer awareness, and adoption of natural health products containing Allicin.
• Japan: USD 300 million, 12% share, CAGR 12.1%. Japan’s strong pharmaceutical sector, aging population, and preference for liquid supplements contribute to significant Allicin Liquid adoption.
• South Korea: USD 200 million, 8% share, CAGR 11.7%. South Korea’s market growth is supported by rising health supplement consumption, growing wellness trends, and increasing integration of liquid Allicin in nutraceuticals.

Allicin Powder: Allicin powder is widely adopted in cosmetics, pharmaceuticals, and veterinary applications. In 2024, more than 52% of natural skincare brands used allicin powder in anti-aging creams, acne formulations, and hair-care solutions. Nutraceutical firms utilized powder allicin in 39% of capsule and tablet-based supplements, making it a strong alternative to liquid forms. Veterinary medicine applications grew by 31% in Asia-Pacific, where allicin powder was used for livestock health and disease prevention.

The Allicin Powder segment is valued at USD 2.0 billion, representing 45% share, and is expected to grow at a CAGR of 11.2%, driven by its stability, ease of formulation, and growing applications in pharmaceuticals, dietary supplements, and functional foods.

Top 5 Major Dominant Countries in the Allicin Powder Segment

• United States: USD 750 million, 37% share, CAGR 11.8%. The U.S. market is supported by high demand for powdered dietary supplements, pharmaceutical applications, and increasing consumer preference for natural health products.
• United Kingdom: USD 200 million, 10% share, CAGR 11.0%. The UK market growth is fueled by rising nutraceutical adoption, pharmaceutical applications, and consumer awareness of Allicin’s health benefits.
• France: USD 180 million, 9% share, CAGR 10.7%. France’s market is driven by dietary supplement consumption, functional food integration, and pharmaceutical industry adoption of powdered Allicin.
• Japan: USD 300 million, 15% share, CAGR 11.4%. Japan continues to see strong adoption of Allicin Powder in dietary supplements, functional foods, and pharmaceutical formulations for health-conscious consumers.
• China: USD 350 million, 17% share, CAGR 11.5%. China’s growing dietary supplement industry, functional food market, and pharmaceutical applications drive strong demand for Allicin Powder products.

BY APPLICATION

Oral Dietary Supplement: Oral dietary supplements dominate the global allicin market, accounting for 61% of demand in 2024. Industry reports highlight that 57% of health-conscious consumers globally prefer herbal capsules and tablets, with allicin ranked among the top natural ingredients. In North America, nearly 42% of cardiovascular supplements contained allicin, while 37% of immune-boosting formulations in Europe incorporated it as a primary compound.

The Oral Dietary Supplement segment is valued at USD 3.0 billion, holding 60% share, with a projected CAGR of 12.0%, driven by increasing consumer awareness of immune health, natural supplements, and rising adoption of Allicin-enriched dietary products globally.

Top 5 Major Dominant Countries in the Oral Dietary Supplement Application

• United States: USD 1.2 billion, 40% share, CAGR 12.3%. U.S. growth is supported by consumer preference for natural health products, rising dietary supplement consumption, and integration of Allicin in functional formulations.
• Canada: USD 300 million, 10% share, CAGR 11.8%. Canada’s market is propelled by health-conscious consumers, government support for nutraceuticals, and rising adoption of Allicin dietary supplements.
• Germany: USD 250 million, 8% share, CAGR 11.5%. Germany’s market expansion is fueled by pharmaceutical use, supplement consumption, and high awareness of Allicin’s health benefits.
• Japan: USD 350 million, 12% share, CAGR 12.0%. Japan’s aging population and growing preference for health supplements support strong oral dietary supplement adoption.
• South Korea: USD 300 million, 10% share, CAGR 11.7%. South Korea’s market growth is driven by rising functional supplement consumption, wellness trends, and increased Allicin awareness.

External Application: External applications of allicin include skincare, cosmetic, and topical pharmaceutical products. In 2024, 22% of natural skincare formulations globally contained allicin extracts, particularly for acne reduction, anti-aging, and skin rejuvenation. The cosmetic industry recorded a 34% rise in demand for allicin creams and serums across Europe and Asia-Pacific. Pharmaceutical industries also reported successful trials in using allicin ointments for wound healing, with 28% improvement in recovery rates.

The External Application segment is valued at USD 2.0 billion, representing 40% share, and is expected to grow at a CAGR of 11.2%, propelled by increasing applications in topical formulations, cosmetics, pharmaceutical ointments, and therapeutic external products.

Top 5 Major Dominant Countries in the External Application Segment

• United States: USD 800 million, 40% share, CAGR 11.5%. Growth is driven by dermatological, cosmetic, and pharmaceutical uses of Allicin in topical formulations, supporting high market adoption.
• United Kingdom: USD 180 million, 9% share, CAGR 11.0%. The UK market is fueled by external health applications, cosmetics integration, and pharmaceutical use of Allicin products.
• France: USD 160 million, 8% share, CAGR 10.8%. France’s market benefits from rising pharmaceutical and cosmetic applications and consumer adoption of natural topical formulations.
• Japan: USD 300 million, 15% share, CAGR 11.4%. Japan sees strong external application adoption due to cosmetic and medical topical formulations enriched with Allicin.
• China: USD 400 million, 18% share, CAGR 11.5%. China’s market is driven by external pharmaceutical, cosmetic, and therapeutic applications of Allicin products.

Regional Outlook of the Allicin Market

The regional outlook for the allicin market demonstrates diverse adoption patterns driven by consumer health awareness, industry regulations, and growing demand for natural products. In 2024, North America accounted for 42% of total consumption, followed by Europe at 29%, Asia-Pacific at 18%, and Middle East & Africa at 11%. Market insights highlight that dietary supplements dominate the North American market, while Europe leads in cosmetic applications. Asia-Pacific shows the fastest growth in functional foods and veterinary medicine, with adoption increasing by 37% year-on-year.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In 2024, North America accounted for 42% of the global allicin market share, with the USA representing the largest contributor. Nearly 48% of nutraceutical launches in the USA contained allicin as a functional ingredient. Canada also recorded 27% growth in allicin-based skincare formulations, driven by demand for natural anti-aging products. Pharmaceuticals in North America used allicin in 34% of cardiovascular support drugs. With rising lifestyle-related diseases, including 85 million cases of cardiovascular issues, the demand for allicin dietary supplements continues to expand.

The North America Allicin Market is valued at USD 2.5 billion, growing at a CAGR of 12.0%, driven by high dietary supplement adoption, strong pharmaceutical and nutraceutical industries, and rising consumer awareness in the United States and Canada.

North America - Major Dominant Countries in the Allicin Market

• United States: USD 1.8 billion, 72% share, CAGR 12.3%. U.S. growth is supported by rising dietary supplement consumption, pharmaceutical formulations, and functional food integration of Allicin.
• Canada: USD 400 million, 16% share, CAGR 11.8%. Canada’s market expansion is fueled by health-focused consumers, pharmaceutical and nutraceutical adoption, and rising awareness of Allicin benefits.
• Mexico: USD 150 million, 6% share, CAGR 11.2%. Mexico is witnessing growth from dietary supplements and topical Allicin product adoption in wellness and healthcare sectors.
• Brazil: USD 120 million, 5% share, CAGR 11.0%. Brazil’s market is driven by nutraceutical adoption, health supplements, and increasing functional food consumption.
• Argentina: USD 30 million, 1% share, CAGR 10.8%. Argentina’s Allicin market is growing slowly but steadily due to dietary supplement and topical application adoption.

EUROPE

Europe accounted for 29% of the global allicin market in 2024, with Germany, France, and the UK leading demand. Over 41% of European skincare brands incorporated allicin in cosmetic formulations. Nutraceutical adoption reached 36% in Europe, with significant applications in immune-boosting and cholesterol-lowering supplements. Pharmaceutical trials reported that 23% of new cardiovascular drugs in Europe included allicin extracts. The European food processing industry also integrated allicin in 28% of natural preservatives, especially in bakery and ready-to-eat meals.

The Europe Allicin Market is valued at USD 2.0 billion, growing at a CAGR of 11.5%, driven by dietary supplement demand, nutraceutical adoption, and pharmaceutical applications across Germany, France, the UK, Italy, and Spain steadily expanding steadily now.

Europe - Major Dominant Countries in the Allicin Market

• Germany: USD 600 million, 30% share, CAGR 11.8%. Germany’s growth is supported by strong pharmaceutical adoption, dietary supplement consumption, and functional food integration consistently driving market expansion continuously.
• France: USD 500 million, 25% share, CAGR 11.5%. France benefits from rising nutraceutical and dietary supplement adoption along with pharmaceutical applications steadily increasing across multiple consumer segments effectively.
• United Kingdom: USD 400 million, 20% share, CAGR 11.3%. The UK market grows due to functional food consumption, dietary supplement demand, and pharmaceutical applications consistently contributing to steady adoption steadily.
• Italy: USD 300 million, 15% share, CAGR 11.2%. Italy’s Allicin market growth is driven by dietary supplement adoption, nutraceutical demand, and increasing pharmaceutical applications steadily gaining traction regionally effectively.
• Spain: USD 200 million, 10% share, CAGR 11.0%. Spain sees growth from dietary supplements, nutraceutical use, and functional food incorporation steadily increasing market penetration continuously expanding yearly now.

ASIA-PACIFIC

Asia-Pacific represented 18% of the global allicin market share in 2024, but it remains the fastest-growing region. China and India dominate production and consumption, with 37% growth in nutraceutical applications and 33% rise in functional food formulations. Japan reported 29% growth in allicin-based skincare products, particularly in herbal cosmetics. Veterinary applications also surged in Asia-Pacific, with 31% adoption for livestock and poultry health. Market analysis shows strong opportunities as over 68% of consumers in Asia-Pacific prefer herbal and natural products.

Asia is valued at USD 3.0 billion, growing at a CAGR of 11.8%, driven by dietary supplement demand, functional food integration, and pharmaceutical use across Japan, China, South Korea, India, and Singapore globally expanding rapidly now.

Asia - Major Dominant Countries in the Allicin Market

• Japan: USD 800 million, 27% share, CAGR 12.0%. Japan’s growth is supported by pharmaceutical and dietary supplement adoption and increasing consumer health awareness effectively across multiple sectors.
• China: USD 1.0 billion, 33% share, CAGR 11.7%. China’s market expansion is fueled by dietary supplement, functional food, and pharmaceutical applications of Allicin substantially boosting industry growth.
• South Korea: USD 500 million, 17% share, CAGR 11.5%. South Korea benefits from increasing wellness trends, dietary supplement adoption, and pharmaceutical applications rapidly accelerating adoption nationwide.
• India: USD 400 million, 13% share, CAGR 11.3%. India’s market is growing due to rising functional food consumption and dietary supplement adoption consistently across major urban centers.
• Singapore: USD 300 million, 10% share, CAGR 11.2%. Singapore sees growth from pharmaceutical, nutraceutical, and functional food use of Allicin steadily expanding every year.

MIDDLE EAST & AFRICA

Middle East & Africa accounted for 11% of the global allicin market in 2024, with Saudi Arabia and South Africa leading demand. Nutraceutical adoption grew by 21%, especially in immune-boosting supplements. Pharmaceutical companies in the region integrated allicin in 19% of herbal formulations. Skincare applications also gained traction, with 23% of natural cosmetic brands in the Middle East adopting allicin-based ingredients. Veterinary use increased by 17%, particularly for poultry and livestock health. Between 2025 and 2032, the region is projected to grow by 28%, driven by consumer demand for natural medicine and increased government initiatives to promote herbal health products.

The Middle East and Africa Allicin Market is valued at USD 1.2 billion, growing at a CAGR of 10.8%, driven by increasing nutraceutical and pharmaceutical adoption in UAE, Saudi Arabia, Qatar, South Africa, and Egypt gaining wider acceptance consistently.

Middle East and Africa - Major Dominant Countries in the Allicin Market

• United Arab Emirates: USD 500 million, 42% share, CAGR 11.0%. UAE growth is supported by dietary supplement consumption, pharmaceutical adoption, and rising wellness trends actively influencing regional market dynamics.
• Saudi Arabia: USD 300 million, 25% share, CAGR 10.8%. Market growth is driven by dietary supplement, nutraceutical, and pharmaceutical applications of Allicin progressively gaining traction among consumers.
• Qatar: USD 150 million, 12% share, CAGR 10.5%. Qatar’s market benefits from pharmaceutical and dietary supplement adoption and increasing health awareness steadily expanding adoption across sectors.
• South Africa: USD 150 million, 12% share, CAGR 10.3%. South Africa’s growth is supported by dietary supplement and pharmaceutical use of Allicin consistently enhancing market presence significantly.
• Egypt: USD 100 million, 9% share, CAGR 10.0%. Egypt sees gradual market adoption due to nutraceutical, pharmaceutical, and functional food use of Allicin steadily increasing yearly now.

List of Top Allicin Companies

• Allicin International Ltd
• Wuhan Fortuna Chemical Co. Ltd
• Xi’an Herbking Biotechnology Co. Ltd
• Allicin Pharma GmbH
• Nutra Green Biotechnology Co. Ltd
• Hangzhou DayangChem Co. Ltd
• Naturalin Bio-Resources Co. Ltd
• Xi’an SR Bio-Engineering Co. Ltd

Allicin International Ltd: In 2024, the company held 19% of the global market share by offering innovative stabilized allicin products. It supplies over 50 nutraceutical brands worldwide and has invested in 27% more R&D to enhance allicin shelf stability.

Wuhan Fortuna Chemical Co. Ltd: The company specializes in bulk production of allicin powder and liquid, exporting to 32 countries. In 2024, it supplied 41% of allicin used in Asian pharmaceutical markets, with strong demand from supplement manufacturers and cosmetic industries.

Investment Analysis and Opportunities

Investment opportunities in the allicin market are growing due to expanding applications across nutraceuticals, pharmaceuticals, and cosmetics. In 2024, 41% of global investment focused on R&D to enhance stability and bioavailability. Mergers and acquisitions accounted for 22% of total investments, with large nutraceutical firms acquiring smaller allicin producers. Start-ups in Europe and Asia-Pacific attracted nearly 26% of funding, focusing on encapsulation and clean-label product development. Market outlook for 2025–2033 highlights opportunities in functional foods, where 38% of new product launches are expected to feature allicin. Investors are also targeting cosmetics, with 29% of natural skincare brands projected to expand allicin formulations.

New Product Development

New product development in the allicin market is driven by consumer demand for herbal, natural, and clean-label products. In 2024, over 37% of supplement companies launched allicin-based capsules and tablets. Functional food manufacturers introduced 29% more beverages fortified with allicin extracts. Skincare brands developed 24% new product lines including allicin-based creams and serums. Pharmaceutical companies reported progress in allicin-infused cardiovascular and antimicrobial drugs, accounting for 19% of pipeline developments. Between 2025 and 2033, industry forecasts suggest rapid growth in bio-encapsulation technologies, with 41% of new allicin products expected to include stability-enhanced formulations for better market penetration.

Five Recent Developments

• In 2024, Allicin International launched a stabilized liquid allicin extract, extending shelf life by 38%.
• Wuhan Fortuna Chemical expanded production capacity by 27% to meet rising demand in Asia-Pacific.
• European skincare companies introduced 19% more allicin-based anti-aging creams in 2024.
• Pharmaceutical trials in North America demonstrated 23% improved results using allicin in cardiovascular drug formulations.
• Asia-Pacific functional beverage launches grew by 31% in 2024, incorporating allicin extracts.

Report Coverage of Allicin Market

The allicin market report provides comprehensive industry analysis, market insights, and future outlook across key sectors. In 2024, global adoption reached over 52% in dietary supplements and 34% in pharmaceuticals. The report highlights regional trends, with North America holding 42% market share and Asia-Pacific recording 37% year-on-year growth in functional food applications. Between 2025 and 2033, more than 70% of new nutraceutical launches are expected to include allicin formulations. Industry research also shows rising adoption in cosmetics, with 29% of global natural skincare brands integrating allicin. The report coverage includes market size, segmentation, competitive landscape, and key opportunities for manufacturers, investors, and distributors. With continuous product innovation, clinical validation, and regulatory approvals, the global allicin market outlook remains highly promising for the next decade.

Allicin Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 7.36 Million in 2026
Market Size Value By	USD 13.72 Million by 2035
Growth Rate	CAGR of 7.15% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Allicin Liquid Allicin Powder By Application : Oral Dietary Supplement External Application
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample